RDY vs. IBN
Compare and contrast key facts about Dr. Reddy's Laboratories Limited (RDY) and ICICI Bank Limited (IBN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RDY or IBN.
Key characteristics
| RDY | IBN | |
|---|---|---|
| YTD Return | 13.83% | 24.42% |
| 1Y Return | 20.48% | 29.81% |
| 3Y Return (Ann) | 6.96% | 16.93% |
| 5Y Return (Ann) | 17.17% | 21.00% |
| 10Y Return (Ann) | 5.39% | 13.89% |
| Sharpe Ratio | 0.98 | 1.39 |
| Daily Std Dev | 20.66% | 22.14% |
| Max Drawdown | -60.53% | -86.09% |
| Current Drawdown | -7.05% | -6.28% |
Fundamentals
| RDY | IBN | |
|---|---|---|
| Market Cap | $13.37B | $105.48B |
| EPS | $3.99 | $1.51 |
| PE Ratio | 19.94 | 19.40 |
| PEG Ratio | 4.58 | 0.00 |
| Total Revenue (TTM) | $225.60B | $1.74T |
| Gross Profit (TTM) | $134.89B | $1.74T |
| EBITDA (TTM) | $43.00B | $138.71B |
Correlation
The correlation between RDY and IBN is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RDY vs. IBN - Performance Comparison
In the year-to-date period, RDY achieves a 13.83% return, which is significantly lower than IBN's 24.42% return. Over the past 10 years, RDY has underperformed IBN with an annualized return of 5.39%, while IBN has yielded a comparatively higher 13.89% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RDY vs. IBN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and ICICI Bank Limited (IBN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RDY vs. IBN - Dividend Comparison
RDY's dividend yield for the trailing twelve months is around 1.22%, more than IBN's 0.81% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RDY Dr. Reddy's Laboratories Limited | 1.22% | 1.39% | 1.48% | 0.52% | 0.47% | 0.70% | 0.77% | 0.84% | 0.66% | 0.68% | 0.60% | 0.64% |
IBN ICICI Bank Limited | 0.81% | 0.81% | 0.57% | 0.28% | 0.00% | 0.19% | 0.84% | 0.79% | 1.98% | 4.21% | 1.32% | 2.02% |
Drawdowns
RDY vs. IBN - Drawdown Comparison
The maximum RDY drawdown since its inception was -60.53%, smaller than the maximum IBN drawdown of -86.09%. Use the drawdown chart below to compare losses from any high point for RDY and IBN. For additional features, visit the drawdowns tool.
Volatility
RDY vs. IBN - Volatility Comparison
The current volatility for Dr. Reddy's Laboratories Limited (RDY) is 3.20%, while ICICI Bank Limited (IBN) has a volatility of 5.86%. This indicates that RDY experiences smaller price fluctuations and is considered to be less risky than IBN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RDY vs. IBN - Financials Comparison
This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and ICICI Bank Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities